Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Acerta, adapt, adapted, adjuvant, Agendia, aggressive, analogize, analogized, Antonio, anxiety, arm, AstraZeneca, Basal, behavior, breast, CE, central, centralized, chemistry, chemotherapy, clause, clinicopathological, cohort, companion, competitor, conclusion, constrained, constraint, contemporaneously, country, cumbersome, custodian, CY, de, developmental, Diffuse, digital, distant, DLBCL, downstream, dozen, dx, Eleven, Eli, EndoPredict, engine, expediting, female, FFPE, flex, footprint, fulfillment, Germinal, grace, GRAIL, greatly, hematology, Hong, HR, hundred, increasingly, installation, installed, intermediary, intervention, investor, IVD, IVDR, journey, justify, Kong, Lancet, licensee, Lilly, linear, locoregional, Luminal, lymph, LymphMark, lymphoma, maker, media, menu, minute, moderated, multiplex, multiplexing, Myriad, NaN, NanoString, NasaRISK, nCounter, nodal, nonclinical, noninvasive, noninvasively, nose, novo, Oncotype, online, overnight, Parliament, Pharma, predicate, predictor, predominantly, proliferation, prompt, proof, propelling, Prosigna, protein, radiological, reach, reached, reclassification, Redwood, remeasured, repurchase, Respiratory, rest, ROU, score, shipment, specialist, speeding, stage, stipulated, subtle, Symposium, tenant, toxic, tumor, unchanged, unclassified, undertreated, unnecessarily, unrealized, unreasonable, vigilance, warranty, wholly, workflow, workforce, Zealand
Removed:
accessioned, assume, burn, China, commerce, conversion, Cooperation, developer, exclusively, exclusivity, fewest, founding, Genzyme, incurring, interstate, iv, Japan, Korea, leased, mix, moratorium, moved, obsolescence, outline, PCT, permanent, PRC, proportionate, provisional, reconciling, reducing, restored, saving, screen, sense, shown, subspecialty, taxation, transforming, transitioned, Treaty, unknown, unmet
Filing tables
Filing exhibits
- 10-K Annual report
- 4.2 VCYT - 2019 10-K Exhibit 4.2
- 10.15 VCYT - 2019 10-K Exhibit 10.15
- 10.16 VCYT - 2019 10-K Exhibit 10.16
- 21.1 VCYT - 2019 10-K Exhibit 21.1
- 23.1 VCYT - 2019 10-K Exhibit 23.1
- 31.1 VCYT - 2019 10-K Exhibit 31.1
- 31.2 VCYT - 2019 10-K Exhibit 31.2
- 32.1 VCYT - 2019 10-K Exhibit 32.1
- 32.2 VCYT - 2019 10-K Exhibit 32.2
- Download Excel data file
- View Excel data file
Related press release
Associated VCYT transcripts
VCYT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statements (Forms S-8 Nos. 333‑191992, 333-203097, 333-210185, 333-216388, 333-223292, and 333-229848) pertaining to the 2008 Stock Plan and 2013 Stock Incentive Plan of Veracyte, Inc., |
(2) | Registration Statement (Form S-8 No. 333-205206) pertaining to the Employee Stock Purchase Plan of Veracyte, Inc., and |
(3) | Registration Statements (Forms S-3 Nos. 333-204368, 333-205204, 333-224576, 333-231153, and 333-231173) of Veracyte, Inc.; |
of our reports dated February 25, 2020, with respect to the consolidated financial statements of Veracyte, Inc. and the effectiveness of internal control over financial reporting of Veracyte, Inc. included in this Annual Report (Form 10-K) of Veracyte, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Redwood City, California
February 25, 2020